Viewing Study NCT03652259

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 2:54 PM
Ignite Modification Date: 2026-01-20 @ 12:16 AM
Study NCT ID: NCT03652259
Status: TERMINATED
Last Update Posted: 2025-09-10
First Post: 2018-08-28
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Gene Delivery Clinical Trial of SRP-9003 (Bidridistrogene Xeboparvovec) for Participants With Limb-Girdle Muscular Dystrophy, Type 2E (LGMD2E) (Beta-Sarcoglycan Deficiency)
Sponsor: Sarepta Therapeutics, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Limb-Girdle Muscular Dystrophy, Type 2E View
Keywords:

Keywords

Keyword Brief Keyword Text View
None limb girdle muscular dystrophy View
None LGMD2E View
None beta-sarcoglycan View
None gene transfer View
None adeno-associated virus View
None LGMDR4 View